Try our Advanced Search for more refined results
June 20, 2014
Avanir Pharmaceuticals Inc. v. Ranbaxy Laboratories Limited et al
Case Number:
1:14-cv-00792
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 23, 2014
Avanir Sues Ranbaxy To Block Generic Nuedexta
Avanir Pharmaceuticals Inc. on Friday filed the latest in a series of suits alleging proposed generic versions of its neurological disorder drug Nuedexta would infringe two of its patents, this time targeting Ranbaxy Laboratories Ltd. in Delaware federal court.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login